Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Lotte S Spekhorst; Lieneke F M Ariëns; Jorien van der Schaft; Daphne S Bakker; Marijke Kamsteeg; Albert J Oosting; Ilona de Ridder; Annemiek Sloeserwij; Geertruida L E Romeijn; Marlies de Graaf; Inge Haeck; Judith L Thijs; Marie L A Schuttelaar; Marjolein S de Bruin-Weller

doi:10.1111/all.14324

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Lotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, Marijke Kamsteeg, Albert J Oosting, Ilona de Ridder, Annemiek Sloeserwij, Geertruida L E Romeijn, Marlies de Graaf, Inge Haeck, Judith L Thijs, Marie L A Schuttelaar, Marjolein S de Bruin-Weller

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

10 Downloads (Pure)

Original language	English
Pages (from-to)	2376-2379
Number of pages	4
Journal	Allergy
Volume	75
Issue number	9
DOIs	https://doi.org/10.1111/all.14324
Publication status	Published - 1 Sept 2020

Access to Document

10.1111/all.14324

all.14324Final published version, 666 KB

Cite this

Spekhorst, L. S., Ariëns, L. F. M., van der Schaft, J., Bakker, D. S., Kamsteeg, M., Oosting, A. J., de Ridder, I., Sloeserwij, A., Romeijn, G. L. E., de Graaf, M., Haeck, I., Thijs, J. L., Schuttelaar, M. L. A., & de Bruin-Weller, M. S. (2020). Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. Allergy, 75(9), 2376-2379. https://doi.org/10.1111/all.14324

@article{fcbacfaa5e5741c8a627c73a6c3b9547,

title = "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry",

author = "Spekhorst, {Lotte S} and Ari{\"e}ns, {Lieneke F M} and {van der Schaft}, Jorien and Bakker, {Daphne S} and Marijke Kamsteeg and Oosting, {Albert J} and {de Ridder}, Ilona and Annemiek Sloeserwij and Romeijn, {Geertruida L E} and {de Graaf}, Marlies and Inge Haeck and Thijs, {Judith L} and Schuttelaar, {Marie L A} and {de Bruin-Weller}, {Marjolein S}",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/all.14324",

language = "English",

volume = "75",

pages = "2376--2379",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "9",

}

Spekhorst, LS, Ariëns, LFM, van der Schaft, J, Bakker, DS, Kamsteeg, M, Oosting, AJ, de Ridder, I, Sloeserwij, A, Romeijn, GLE, de Graaf, M, Haeck, I, Thijs, JL, Schuttelaar, MLA & de Bruin-Weller, MS 2020, 'Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry', Allergy, vol. 75, no. 9, pp. 2376-2379. https://doi.org/10.1111/all.14324

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. / Spekhorst, Lotte S; Ariëns, Lieneke F M; van der Schaft, Jorien et al.
In: Allergy, Vol. 75, No. 9, 01.09.2020, p. 2376-2379.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate

T2 - Results from the BioDay registry

AU - Spekhorst, Lotte S

AU - Ariëns, Lieneke F M

AU - van der Schaft, Jorien

AU - Bakker, Daphne S

AU - Kamsteeg, Marijke

AU - Oosting, Albert J

AU - de Ridder, Ilona

AU - Sloeserwij, Annemiek

AU - Romeijn, Geertruida L E

AU - de Graaf, Marlies

AU - Haeck, Inge

AU - Thijs, Judith L

AU - Schuttelaar, Marie L A

AU - de Bruin-Weller, Marjolein S

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85085097346&partnerID=8YFLogxK

U2 - 10.1111/all.14324

DO - 10.1111/all.14324

M3 - Comment/Letter to the editor

C2 - 32302412

SN - 0105-4538

VL - 75

SP - 2376

EP - 2379

JO - Allergy

JF - Allergy

IS - 9

ER -

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Access to Document

Other files and links

Cite this